Ausgabe 3/2004
Inhalt (22 Artikel)
DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status
Isabel Conde, Juan M Alfaro, Benito Fraile, Antonio Ruíz, Ricardo Paniagua, Maria I Arenas
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge
Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin
Katayoun Alavi Jessen, Stephenie Y Liu, Clifford G Tepper, Juliana Karrim, Erik T McGoldrick, Andrea Rosner, Robert J Munn, Lawrence JT Young, Alexander D Borowsky, Robert D Cardiff, Jeffrey P Gregg
Estrogen receptor-α polymorphism in a Taiwanese clinical breast cancer population: a case–control study
Wei-Chiang Hsiao, Kung-Chia Young, Shoei-Loong Lin, Pin-Wen Lin
Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study
Jonine L Bernstein, Bryan Langholz, Robert W Haile, Leslie Bernstein, Duncan C Thomas, Marilyn Stovall, Kathleen E Malone, Charles F Lynch, Jørgen H Olsen, Hoda Anton-Culver, Roy E Shore, John D Boice Jr, Gertrud S Berkowitz, Richard A Gatti, Susan L Teitelbaum, Susan A Smith, Barry S Rosenstein, Anne-Lise Børresen-Dale, Patrick Concannon, W Douglas Thompson
Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]
Charlotte Atkinson, Ruth ML Warren, Evis Sala, Mitch Dowsett, Alison M Dunning, Catherine S Healey, Shirley Runswick, Nicholas E Day, Sheila A Bingham
A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer
Xiao-Lei Zhou, Barbro Werelius, Annika Lindblom
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Günther Gruber, Richard H Greiner, Ruslan Hlushchuk, Daniel M Aebersold, Hans J Altermatt, Gilles Berclaz, Valentin Djonov
Identification of signaling pathways in early mammary gland development by mouse genetics
Gertraud W Robinson
Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro
Kimberly A Brown, Mary E Aakre, Agnieska E Gorska, James O Price, Sakina E Eltom, Jennifer A Pietenpol, Harold L Moses
Changes in magnetic resonance mammography due to hormone replacement therapy
Stefan OR Pfleiderer, Steffen Sachse, Dieter Sauner, Christiane Marx, Ansgar Malich, Susanne Wurdinger, Werner A Kaiser
Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells
Haiyan Pang, Brian G Rowan, Mariam Al-Dhaheri, Lee E Faber
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
Kathy D Miller
Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling
Sian M Tovey, Caroline J Witton, John MS Bartlett, Peter D Stanton, Jonathan R Reeves, Timothy G Cooke
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
Ivan Bièche, Igor Girault, Estelle Urbain, Sengül Tozlu, Rosette Lidereau
Essential function for ErbB3 in breast cancer proliferation
Elena Perez-Nadales, Alison C Lloyd